Literature DB >> 20145421

Screening for diabetic retinopathy: a comparative trial of photography and scanning laser ophthalmoscopy.

P J Wilson1, J D Ellis, C J MacEwen, A Ellingford, J Talbot, G P Leese.   

Abstract

AIMS: To evaluate the sensitivity and specificity of wide-field scanning laser ophthalmoscopy (WSLO) in the detection of referable diabetic eye disease, and to compare its performance with digital retinal photography.
METHODS: Patients enrolled into the study underwent non-mydriatic WSLO imaging, then single- and dual-field mydriatic digital retinal photography, and examination with slit lamp biomicroscopy, the reference standard. Grading of retinopathy was performed in a masked fashion.
RESULTS: A total of 380 patients (759 eyes) were recruited to the study. Technical failure rates for dilated single-field retinal photography, dual-field retinal photography and undilated WSLO were 6.3, 5.8 and 10.8%, respectively (0.005 < p < 0.02 for photography vs. WSLO). The respective indices for screening sensitivity were 82.9, 82.9 and 83.6% (p > 0.2). Specificity was 92.1, 91.1 and 89.5%, respectively (p > 0.2).
CONCLUSIONS: Sensitivity and specificity for WSLO were similar to retinal photography. The technical failure rate was greater for the WSLO used in this study.

Entities:  

Mesh:

Year:  2010        PMID: 20145421     DOI: 10.1159/000284351

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  13 in total

1.  Quantification of Retinal Nonperfusion and Neovascularization With Ultrawidefield Fluorescein Angiography in Patients With Diabetes and Associated Characteristics of Advanced Disease.

Authors:  Gina Yu; Michael T Aaberg; Tapan P Patel; Rahul S Iyengar; Corey Powell; Annie Tran; Caitlin Miranda; Emma Young; Katarina Demetriou; Laxmi Devisetty; Yannis M Paulus
Journal:  JAMA Ophthalmol       Date:  2020-06-01       Impact factor: 7.389

2.  Comparison of image-assisted versus traditional fundus examination.

Authors:  Kristen Brown; Jeanette M Sewell; Clement Trempe; Tunde Peto; Thomas G Travison
Journal:  Eye Brain       Date:  2013-02-13

Review 3.  Ultra widefield fundus imaging for diabetic retinopathy.

Authors:  Szilárd Kiss; Thomas L Berenberg
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

Review 4.  Clinical Components of Telemedicine Programs for Diabetic Retinopathy.

Authors:  Mark B Horton; Paolo S Silva; Jerry D Cavallerano; Lloyd Paul Aiello
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

5.  Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: a randomized controlled trial.

Authors:  Steven L Mansberger; Ken Gleitsmann; Stuart Gardiner; Christina Sheppler; Shaban Demirel; Kathleen Wooten; Thomas M Becker
Journal:  Telemed J E Health       Date:  2013-10-08       Impact factor: 3.536

6.  Role of early screening for diabetic retinopathy in patients with diabetes mellitus: an overview.

Authors:  Praveen Vashist; Sameeksha Singh; Noopur Gupta; Rohit Saxena
Journal:  Indian J Community Med       Date:  2011-10

7.  Optomap ultrawide field imaging identifies additional retinal abnormalities in patients with diabetic retinopathy.

Authors:  Liam D Price; Stephanie Au; N Victor Chong
Journal:  Clin Ophthalmol       Date:  2015-03-24

8.  Wide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening.

Authors:  V Manjunath; V Papastavrou; D H W Steel; G Menon; R Taylor; T Peto; J Talks
Journal:  Eye (Lond)       Date:  2015-01-16       Impact factor: 3.775

9.  White Dots as a Novel Marker of Diabetic Retinopathy Severity in Ultrawide Field Imaging.

Authors:  Yoko Dodo; Tomoaki Murakami; Noriyuki Unoki; Ken Ogino; Akihito Uji; Shin Yoshitake; Nagahisa Yoshimura
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

10.  A randomised trial of non-mydriatic ultra-wide field retinal imaging versus usual care to screen for diabetic eye disease: rationale and protocol for the Clearsight trial.

Authors:  Selina L Liu; Lewis W Mahon; Neil S Klar; David C Schulz; John R Gonder; Irene M Hramiak; Jeffrey L Mahon
Journal:  BMJ Open       Date:  2017-08-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.